The h1n1 vaccine global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
H1N1 Vaccine Market, 2024 report by The Business Research Company offers
comprehensive insights into the current state of the market and highlights
future growth opportunities.
Market Size -
The h1n1 vaccine market size has grown strongly in recent years. It will grow
from $3.16 billion in 2023 to $3.37 billion in 2024 at a compound annual growth
rate (CAGR) of 6.8%. The growth in the historic period can be
attributed to previous influenza outbreaks, global health security concerns,
vaccine development and approval processes, global vaccination campaigns,
public health education initiatives, government funding and subsidies,
pharmaceutical industry agility.
The h1n1 vaccine market size is expected to see strong growth in the next few
years. It will grow to $4.46 billion in 2028 at a compound annual growth rate
(CAGR) of 7.2%. The growth in the
forecast period can be attributed to research on broad-spectrum vaccines,
global vaccine equity initiatives, public health resilience building, global
health governance strengthening, integration of h1n1 vaccination with routine
immunization. Major trends in the forecast period include global pandemic
preparedness, influenza vaccination programs, vaccine development advances,
cross-protection research, global health initiatives, technological improvements
in vaccine manufacturing, production capacity expansion, data monitoring and
surveillance.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report
Scope Of H1N1 Vaccine Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
H1N1 Vaccine Market Overview
Market Drivers -
The increase in expenditure for research and development activities in the
field of immunology and vaccine is expected to propel the growth of the H1N1
vaccine market going forward. Immunology and vaccines are used to prevent
infections and help in producing antibodies to fight infections. Immunology is
a crucial area of research in the medical and biological sciences that focuses
on understanding the immune system. The H1N1 vaccine is a preparation used to
boost antibody production, which provides immunity against a variety of
diseases. For instance, according to an article by the kENUP Foundation, a
Europe-based non-profit supporting research-based innovation in health
industries, in January 2021, governments spent at least $94.11 billion (€93
billion) on the development of vaccines and treatments since the start of the
pandemic worldwide. The public sector committed 95% of the total spending, or
$87.54 billion (€86.5 billion), in just 11 months to the development of
vaccinations. Therefore, increasing expenditure for research and development
activities in the field of immunology and vaccines is driving the growth of the
H1N1 vaccine market.
Market Trends -
Strategic collaborations between companies is a key trend that is gaining
popularity in the H1N1 (swine flu) vaccination market. Companies in the H1N1
(swine flu) Vaccination market are focusing on strategic collaborations to
expand their market share. For instance, in August 2022, A significant, a
pharmaceutical company and Open Orphan affiliate hVIVO have agreed to an
agreement for $123 million to create a brand-new batch of H1N1 influenza
challenge virus. This has stimulated the growth potential of both companies in
the industry.
The h1n1 vaccine market covered in this report is segmented –
1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination, Intramuscular
Vaccination, Subcutaneous Vaccination
3) By End Users: Hospitals, Clinics, Research and Diagnostic Laboratories,
Other End Users
Get an inside scoop of the h1n1 vaccine market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=7881&type=smp
Regional Insights -
North America was the largest region in the H1N1 vaccine market in 2023. The
regions covered in the h1n1 vaccine market report are Asia-Pacific, Western
Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies -
Major companies operating in the h1n1 vaccine market report are Sanofi SA,
Novartis AG, GlaxoSmithKline plc, CSL Limited, AstraZeneca Inc., Zydus
Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Baxter Laboratories
Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott
Laboratories, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Seqirus Ltd.,
Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc.,
Changsheng Bio-Technology Co. Ltd., Takeda Pharmaceutical Ltd., Bharat Biotech
International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT
Kalbe Farma Tbk, Daiichi Sankyo Chemical Pharma Co. Ltd., Johnson & Johnson
Services Inc., F. Hoffmann-La Roche Ltd., Moderna Inc., CureVac NV, BioNTech
SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax
Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.
Table of Contents
1. Executive Summary
2. H1N1 Vaccine Market Report Structure
3. H1N1 Vaccine Market Trends And Strategies
4. H1N1 Vaccine Market – Macro Economic Scenario
5. H1N1 Vaccine Market Size And Growth
…..
27. H1N1 Vaccine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment